FDA-approved Esketamine (Spravato®) treatment is an innovative and evidence-based option for individuals struggling with treatment-resistant depression.  Unlike traditional antidepressants, which can take weeks to take effect, Spravato® often provides rapid relief of depressive symptoms—sometimes within hours. Administered under the supervision of trained medical professionals, Spravato® works by targeting the brain’s glutamate system to promote neural growth and restore healthy brain function.   For those who have not found success with conventional treatments, Spravato® therapy offers a promising alternative that can significantly improve quality of life.